USA-Kenya Trade Agreement: No IP barriers to affordable medicines
Call to action News“Access to medicines is a fundamental element of the right to health” states our partner, the Kenya Legal and Ethical...
Read more about USA-Kenya Trade Agreement: No IP barriers to affordable medicines
-
CPTPP: Global civil society writes to Thai Prime Minister warning access to treatment is at risk
Call to action NewsCivil society groups and non-government organizations in Thailand have, since March 2020, been expressing their grave concerns over the adverse...
-
CSO Open Letter to Thailand’s Prime Minister
Call to action NewsCSO Open Letter to Thailand’s Prime Minister and the Chairperson of the Special Committee on the Study of the CPTPP’s...
Read more about CSO Open Letter to Thailand’s Prime Minister
-
Belarus: Civil society pushes for compulsory license as dolutegravir remains overpriced
Call to action NewsPositive Movement (PMPlus) in Belarus, one of our partner organizations, is an NGO representing people living with HIV, advocating for...
-
Thai civil society opposes patent on an influenza drug, now used for COVID-19
NewsFavipiravir, originally approved as an influenza drug, is being used to treat COVID-19 patients with pneumonia, alongside anti-malarial and anti-retroviral...
Read more about Thai civil society opposes patent on an influenza drug, now used for COVID-19
-
Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
Call to action News Press releaseThis week, civil society in Morocco has called for the urgent removal of unnecessary legal barriers, which are “tailor-made for...
Read more about Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
-
Russian NGOs oppose Gilead’s patent for HIV drug, Truvada
NewsHumanitarian Action with technical support from ITPCru has opposed Gilead’s patent in Russia for the combination of two antiretroviral drugs,...
Read more about Russian NGOs oppose Gilead’s patent for HIV drug, Truvada
-
Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia
News Press releaseDolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...
-
New data: Treat HIV for just four weeks of global pharmaceutical sales
News Press releaseThe Make Medicines Affordable campaign is calling for a widespread switch from patented to generic HIV drugs so that at...
Read more about New data: Treat HIV for just four weeks of global pharmaceutical sales
-
AIDS 2020 leadership workshop: Strategies for lowering drug prices
NewsActivists, policy-makers, researchers and healthcare providers joined a leadership workshop led by ITPC’s Make Medicines Affordable campaign at AIDS 2020...
Read more about AIDS 2020 leadership workshop: Strategies for lowering drug prices
